Health Care · Hospital & Medical Service Plans

CNC Centene Corporation SEC Filings & Insider Trading Activity 2026

company
CIK 1071739106 filings
S&P 500

CNC at a glance

Centene Corporation (CNC, SEC CIK 1071739) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and Form 4 insider filings as recently as October 15, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Centene Corporation (CNC) reported revenue of $174.6 billion (up 20.0% from FY2024) and a net loss of $6.7 billion. Diluted EPS was -$13.53.
  • As of September 30, 2026, 38 institutional investment managers tracked by SignalX reported holding Centene Corporation (CNC) shares worth $15.1 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by KOSTER CHRISTOPHER on August 26, 2026 of 56,500 shares at $66.90 per share.
  • In the last 90 days, CNC insiders reported 0 open-market purchases ($0) and 1 open-market sale ($3.8M) on Form 4, a net sale of $3.8M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$174.6B
+20.0% vs prior year
Insiders · 90 days
0 buys · 1 sell
Net −$3.8M
13F holders
38 funds
$15.1B · −1 vs prior quarter
Latest 8-K
Oct 27, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • CMS audit intensification risk with expanded risk adjustment data validation audits since 2025, potentially causing premium refunds and reducing revenue materially
  • Texas and Georgia Medicaid reprocurement loss risk, involving protests due to unsuccessful bidding, threatening contract renewals and associated revenues
  • Elevated medical cost risk from 2025 Marketplace membership with unexpectedly higher morbidity reducing net risk adjustment revenue significantly
  • Part D bid risk from IRA-induced increased costs and enrollment volatility, with PDP membership boosted to 8.7 million in 2026 due to below-benchmark bids
  • Medicare Advantage Star ratings risk with 40% of membership below 3.5 stars and contract terminations notices for 2025 impacting profitability and contract retention

Business Overview

  • Core business model not directly described; document is primarily governance and regulatory disclosures
  • No new products, services, or segments introduced or emphasized in this section
  • Strategic shifts or competitive positioning not addressed in this text
  • Independent auditor for FY 2026 confirmed as KPMG LLP, Auditor Firm ID 185
  • Filing mainly references Proxy Statement for detailed governance, executive compensation, and ownership information

Management Discussion & Analysis

  • Revenue details not explicitly provided; 2025 Medicaid membership 12.5M, Marketplace 5.5M, Medicare Advantage 1.0M, PDP 8.1M members
  • No direct profitability or margin % figures disclosed in the text
  • Best segments by membership: Medicaid 12.5M members, weakest not specified
  • Capital allocation specifics (buybacks, dividends, capex) not detailed; $1.3B Magellan Rx divestiture gain $269M pre-tax; other divestitures totaling ~$1.6B in proceeds and related gains
  • Forward outlook: 2026 Marketplace morbidity expected to increase; medical costs rising accelerated by policy and market changes; OBBBA impacts Medicaid eligibility and funding by 2027; CMS Medicare risk-sharing adjustments and integrated D-SNP requirement beginning 2027

AI summary of the CNC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to risk factors since Centene’s 2025 Form 10-K
  • Carried-forward risks remain applicable, but specific categories are not detailed in this filing excerpt

Management Discussion & Analysis

  • Revenue $50.647B, up 2% YoY from $49.690B
  • HBR 92.7% vs 92.7% YoY, SG&A ratio 7.2% vs 7.0%
  • Medicare strongest: revenue $11.263B, up 20%; Commercial weakest, revenue $8.700B, down 21%
  • Operating cash flow used $3.7B in Q3, driven by pass-through payment timing
  • Outlook: elevated medical-cost trend, Medicaid redeterminations, Marketplace membership declines and regulatory uncertainty

AI summary of the CNC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 27, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Third-quarter results for the period ended September 30, 2026 announced October 27, 2026
  • Full financial results available in Exhibit 99.1, the key source for revenue, earnings and guidance details

Item EX-99.1: Item EX-99.1

  • Q3 revenue $50.6B, premium revenue $45.1B, up 0.5% year over year
  • Adjusted EPS $0.58 despite GAAP loss $(0.14), with adjusted SG&A ratio improving to 6.5%
Filed Oct 8, 2026Full analysis →

Item 8.01: Other Events

  • Centene plans to redeem all remaining $568.664 million of 4.25% notes on October 23, 2026
  • Redemption price: 100% of principal plus accrued interest through October 22, 2026
Filed Sep 16, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Management reaffirmed 2026 GAAP diluted EPS guidance above $3.11
  • Adjusted diluted EPS guidance reaffirmed above $4.80 for full-year 2026

AI summaries of CNC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for CNC

Don't miss the next CNC filing

  • Alerts as it files. A push when CNC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut CNC, by share count.
  • Ask anything. An AI agent that reads every CNC filing and answers with sources.

CNC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Carson Michael AFOct 15, 2026$70.16
EPPINGER FREDERICK HASep 30, 2026-
COUGHLIN CHRISTOPHER JASep 30, 2026-
Samuels Theodore R. IIASep 30, 2026-
Tyler Lauren MASep 30, 2026-
TANJI KENNETHASep 30, 2026-
PIENKOS THEODORE JFSep 15, 2026$69.41
KOSTER CHRISTOPHERSellAug 26, 2026$66.90

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$145.5B$174.6B
Gross Profit-$17.1B$14.2B
Operating Income-$3.2B-$7.6B
Net Income-$3.3B-$6.7B
Gross Margin-11.7%8.1%
Op. Margin-2.2%-4.4%
Net Margin-2.3%-3.8%
Balance Sheet
Total Assets$84.6B$82.4B$76.7B
Equity-$26.4B$20.0B
ROE-12.5%-33.4%
Per Share
EPS-$6.31$-13.53
Cash Flow
Operating CF-$154.0M$5.1B
CapEx$799.0M$644.0M$767.0M

Source: XBRL data in Centene Corporation (CNC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate CNC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
CNC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202638$15.07B
Q2 202639$15.16B
Q1 202639$7.64B
Q4 202536$9.97B
Q3 202537$8.41B
Q2 202537$12.13B
Q1 202533$10.84B
Q4 202431$9.81B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 290 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

CNC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KOct 27, 2026Analysis-
10-QOct 27, 2026Analysis
4Oct 15, 2026--
8-KOct 8, 2026Analysis-
4Sep 30, 2026--
4Sep 30, 2026--
4Sep 30, 2026--
4Sep 30, 2026--
4Sep 30, 2026--
8-KSep 16, 2026Analysis-
4Sep 16, 2026--
4Aug 27, 2026--
4Aug 19, 2026--
8-KAug 17, 2026Analysis-
8-KJul 29, 2026Analysis-
4Jul 28, 2026--
8-KJul 28, 2026Analysis-
10-QJul 28, 2026Analysis
4Jul 20, 2026--
4Jul 1, 2026--
4Jul 1, 2026--
4Jul 1, 2026--
4Jul 1, 2026--
4Jul 1, 2026--
8-KJun 22, 2026Analysis-

Related Health Care companies

All Health Care →

CNC SEC filings: frequently asked questions

Are CNC insiders buying or selling?

In the last 90 days, Centene Corporation (CNC) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $3.8 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold CNC stock?

As of September 30, 2026, the largest Centene Corporation (CNC) holders among the 13F filers tracked by SignalX were BlackRock ($2.8 billion), Vanguard Capital Management LLC ($2.0 billion), AQR Capital Management ($1.9 billion), State Street Corp ($1.4 billion), Vanguard Portfolio Management LLC ($1.4 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was CNC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Centene Corporation (CNC) reported revenue of $174.6 billion (up 20.0% from FY2024) and a net loss of $6.7 billion. Diluted EPS was -$13.53. The figures come from the XBRL data in the 10-K.

What are the main risks in CNC's latest 10-K?

In the 10-K filed February 17, 2026, Centene Corporation (CNC) flagged: CMS audit intensification risk with expanded risk adjustment data validation audits since 2025, potentially causing premium refunds and reducing revenue materially. Texas and Georgia Medicaid reprocurement loss risk, involving protests due to unsuccessful bidding, threatening contract renewals and associated revenues. (AI summary of the Risk Factors section.)

What did CNC report in its latest 8-K?

Centene Corporation (CNC) filed an 8-K on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Third-quarter results for the period ended September 30, 2026 announced October 27, 2026.

What are the latest CNC SEC filings?

Centene Corporation (CNC) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and a Form 4 insider filing on October 15, 2026.

What is CNC's SEC CIK number?

Centene Corporation (CNC)'s SEC Central Index Key (CIK) is 1071739. EDGAR lists every CNC filing under that number.

Ask anything about CNC

The research agent reads CNC's filings, financials, insider trades and 13F holders, then answers with sources.